These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23607936)

  • 21. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
    Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
    Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart.
    Gao Q; Pan HY; Qiu S; Lu Y; Bruce IC; Luo JH; Xia Q
    Life Sci; 2006 Jun; 79(3):217-24. PubMed ID: 16458326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium nitrite and cardioprotective effect in pig regional myocardial ischemia-reperfusion injury model.
    Doganci S; Yildirim V; Bolcal C; Korkusuz P; Gumusel B; Demirkilic U; Aydin A
    Adv Clin Exp Med; 2012; 21(6):713-26. PubMed ID: 23457128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine A normalizes mitochondrial coupling, reactive oxygen species production, and inflammation and partially restores skeletal muscle maximal oxidative capacity in experimental aortic cross-clamping.
    Pottecher J; Guillot M; Belaidi E; Charles AL; Lejay A; Gharib A; Diemunsch P; Geny B
    J Vasc Surg; 2013 Apr; 57(4):1100-1108.e2. PubMed ID: 23332985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.
    Hall AR; Burke N; Dongworth RK; Kalkhoran SB; Dyson A; Vicencio JM; Dorn GW; Yellon DM; Hausenloy DJ
    Cell Death Dis; 2016 May; 7(5):e2238. PubMed ID: 27228353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late sodium current inhibition alone with ranolazine is sufficient to reduce ischemia- and cardiac glycoside-induced calcium overload and contractile dysfunction mediated by reverse-mode sodium/calcium exchange.
    Soliman D; Wang L; Hamming KS; Yang W; Fatehi M; Carter CC; Clanachan AS; Light PE
    J Pharmacol Exp Ther; 2012 Nov; 343(2):325-32. PubMed ID: 22879384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore.
    Alizadeh AM; Faghihi M; Khori V; Sohanaki H; Pourkhalili K; Mohammadghasemi F; Mohsenikia M
    Peptides; 2012 Jul; 36(1):71-7. PubMed ID: 22504012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemia time impacts on respiratory chain functions and Ca
    Leistner M; Sommer S; Kanofsky P; Leyh R; Sommer SP
    J Cardiothorac Surg; 2019 May; 14(1):92. PubMed ID: 31088484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective efficacy of a novel antioxidant mix VitaePro against ex vivo myocardial ischemia-reperfusion injury.
    Adluri RS; Thirunavukkarasu M; Zhan L; Maulik N; Svennevig K; Bagchi M; Maulik G
    Cell Biochem Biophys; 2013 Nov; 67(2):281-6. PubMed ID: 21960420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic protective effect of cyclosporin A and rotenone against hypoxia-reoxygenation in cardiomyocytes.
    Teixeira G; Abrial M; Portier K; Chiari P; Couture-Lepetit E; Tourneur Y; Ovize M; Gharib A
    J Mol Cell Cardiol; 2013 Mar; 56():55-62. PubMed ID: 23238221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of N-(2-mercaptopropionyl)-glycine against ischemia-reperfusion injury in hypertrophied hearts.
    Fantinelli JC; González Arbeláez LF; Pérez Núñez IA; Mosca SM
    Exp Mol Pathol; 2013 Feb; 94(1):277-84. PubMed ID: 22850634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusion.
    Xie JR; Yu LN
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):909-13. PubMed ID: 17578461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4'-Chlorodiazepam, a translocator protein (18 kDa) antagonist, improves cardiac functional recovery during postischemia reperfusion in rats.
    Xiao J; Liang D; Zhang H; Liu Y; Li F; Chen YH
    Exp Biol Med (Maywood); 2010 Apr; 235(4):478-86. PubMed ID: 20407080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats.
    Lin C; Sui H; Gu J; Yang X; Deng L; Li W; Ding W; Li D; Yang Y
    Microvasc Res; 2013 Nov; 90():162-8. PubMed ID: 23988878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
    Hausenloy D; Wynne A; Duchen M; Yellon D
    Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibition of mitochondrial permeability transition pore is one of the mechanisms of cardioprotective effect of coenzyme Q10].
    Sahach VF; Vavilova HL; Rudyk OV; Dobrovol's'kyĭ FV; Shymans'ka TV; Miedviediev OS
    Fiziol Zh (1994); 2007; 53(4):35-42. PubMed ID: 17902369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.